About Michael Dial
Form D filings for Atsena Therapeutics from 2020 to 2023 list Michael Dial as director.
Michael Dial first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Dial in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Dial works with at each company, as listed on that company's latest Form D.
Atsena Therapeutics, Inc. · Form D, Oct 2, 2023
JW
Jennifer Wellman
Director
JG
Jacqueline Grant
Director
PR
Patrick Ritschel
Chief Executive Officer and director
SB
Shannon Boye
Director
EL
Elizabeth Leiderman
Executive officer
JH
James Healy
Director
CI
Christina Isacson
Director